Showing results (721-730 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|February 16, 2026
Thymectomy with or without maintenance therapy for myasthenia gravis patients: a tri-center, real-world studyHao Zhang, Moli Fan, Yutong Shi, et al.Therapeutic Advances in Neurological Disorders|December 9, 2025
Brain volumetry and spinal cord imaging in patients with AQP4-IgG+ NMOSD-a systematic review and meta-analysisJosephine Heine, Claudia ChienTherapeutic Advances in Neurological Disorders|November 27, 2025
Association of hemodynamic variability during endovascular stroke treatment with functional outcome and parenchymal hemorrhageMin Chen, Lukas D Sauer, Arne Potreck, et al.Therapeutic Advances in Neurological Disorders|November 21, 2025
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting SystemAfsaneh Shirani, Samuel A Goldlust, Olaf StuveTherapeutic Advances in Neurological Disorders|November 13, 2025
Clinical factors associated with perampanel retention, response, seizure freedom and tolerability: real-world evidence from the PERMIT Extension studyTaoufik Alsaadi, Patricia Penovich, Stéphane Auvin, et al.Therapeutic Advances in Neurological Disorders|November 13, 2025
Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunologyJonathan Wickel, Jeremias Motte, Ilya Ayzenberg, et al.Therapeutic Advances in Neurological Disorders|December 29, 2025
Advancements and challenges of adherence to secondary prevention medications among patients with ischemic stroke or transient ischemic attack: the healthcare quality improvement in China, 2007-2018Yuan Shen, Xinya Li, Xue Xia, et al.Therapeutic Advances in Neurological Disorders|December 19, 2025
Appropriate use of steroids for patients with generalized Myasthenia Gravis: an international Delphi studyHeinz Wiendl, Hiroyuki Murai, Pushpa Narayanaswami, et al.Therapeutic Advances in Neurological Disorders|December 15, 2025
CAR T-cell therapy for neurological disorders: scientific rationale and mechanistic insightsDimitrios E Katsaros, Dimitrios MougiakakosTherapeutic Advances in Neurological Disorders|December 25, 2025
Efficacy of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy with or without diabetes: insights from a multicenter prospective comparative studySamir P Macwan, Shalini Mahajan, Peter Novak, et al.Pageof 108